• IBM stops development, sales of Watson for Drug Discovery

    IBM has discontinued the development and sales of its Watson for Drug Discovery product due to poor financial performance, according to STAT.
  • Gilead, machine learning startup test AI's drug development potential

    Gilead Sciences, the Foster City, Calif.-based biopharmaceutical company, has teamed up with insitro, a machine learning startup in San Francisco, to develop disease treatments using artificial intelligence.
  • AI-driven apps are coaching digital-first millennial managers

    Millennials, now in their 20s and 30s, are increasingly moving into high-ranking supervisor roles, often with little to no formal management training. To bridge this gap, many turn to artificial intelligence-powered systems to coach them through their managerial responsibilities, according to the Wall Street Journal.
  • Research roadmap details path to incorporating AI into radiology

    Researchers have already begun to develop artificial intelligence tools for use in medical imaging but, as described in a new report published in the journal Radiology, more progress is necessary before these machine learning systems reach their full potential.
  • Intuit CIO shares strategies for successful AI integration

    As automation and robotics continue to simplify critical processes and take over menial tasks across industries, it may be tempting to integrate artificial intelligence into every aspect of a business. But companies should resist that urge, according to Intuit CIO Atticus Tysen.
  • Viewpoint: AI holds promise, but won't solve medicine's biggest problems

    While artificial intelligence will only continue to make strides in disease detection and treatment, those counting on AI technology to completely cure life-threatening illnesses within just a few years would do well to lower their expectations, according to Jason Moore, PhD, director of the University of Pennsylvania's Institute for Biomedical Informatics at the Perelman School of Medicine.
  • Yale New Haven tests driverless hospital shuttles

    A shuttle between Connecticut-based Yale New Haven Hospital's two main campuses and parking facilities could be completely driverless within just a few years, if the city's application to a state pilot program is approved, the New Haven Register reports.
  • Harvard Medical School's AI screening system could produce more accurate cancer treatment programs

    An artificial intelligence screening system developed by scientists at Harvard Medical School in Cambridge, Mass., can identify homologous recombination deficiency, a cancer-causing genetic defect that often goes undetected, according to a press release. If integrated into widespread use, the AI system could expand treatment options for cancer patients with HR deficiency.
  • Approving AI for medical use: 7 things to know

    The FDA grants approval for drugs and medical devices, but as artificial intelligence continues to grow in healthcare, the agency also is tasked with ensuring computer algorithms are both safe and effective, NPR reports.
  • Google quietly disbands another AI advisory board

    Google is in the processes of dismantling a panel that aims at reviewing its artificial intelligence solutions in healthcare, according to The Wall Street Journal.
  • Partners HealthCare pledges to make AI tools accessible to clinicians, researchers

    Boston-based Partners HealthCare will roll out artificial intelligence tools for all its clinicians and researchers over the next year.
  • 6 trends in blockchain and AI

    Blockchain and artificial intelligence are helping healthcare and other industries become more digital.
  • 17% of companies have full-scale intelligent automation

    Most large companies are taking a piecemeal approach to smart technology deployments, according to a KPMG survey featured in The Wall Street Journal.
  • Deep Lens raises $14M for AI-powered clinical trial recruitment

    Deep Lens, an artificial intelligence digital pathology company, received $14 million in funding to expand its AI platform for recruiting clinical trial participants.
  • Vox Media: AI can easily be fooled

    Artificial intelligence algorithms are vulnerable to "adversarial attacks," which are inexpensive and easy to carry out, according to a report from Vox.
  • American College of Radiology, Nvidia team up to deploy AI in radiology

    The American College of Radiology and tech firm Nvidia are deploying free artificial intelligence software for radiologists to help spur AI adoption.
  • Berkeley Lab researchers use AI to determine veterans' suicide risk

    Lawrence Berkeley (Calif.) National Laboratory researchers are applying artificial intelligence and analytics to EHR data to help the Department of Veterans Affairs identify veterans' risk of suicide.
  • Google pulls plug on AI, tech advisory board

    Google canceled the artificial intelligence global advisory council it announced March 26 due to controversy among its board members, Vox reports.
  • Top AI Google employee jumps ship to Apple

    One of Google’s top artificial intelligence employees, Ian Goodfellow, left the company to join Apple, according to CNBC.
  • AI may be able to determine success of IVF embryo implantations, study shows

    New York City-based Weill Cornell Medicine researchers developed an artificial intelligence-powered, deep neural network for embryo image analysis that may predict success rates of in vitro fertilization treatments, according to a study published in NPJ Digital Medicine.

Top 40 Articles from the Past 6 Months